Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
27,4 EUR | +1,88% | +4,08% | -18,53% |
26/04 | Il CEO di Bayer vince il primo voto degli azionisti all'AGM | RE |
26/04 | BAYER AFFERMA CHE GLI INVESTITORI CON IL 91,69% DEL CAPITALE AZIONARIO RAPPRESENTATI... | RE |
Attività
- prodotti agrochimici (48,8%): erbicidi, fungicidi, insetticidi, ecc;
- prodotti farmaceutici (38%): destinati alla prevenzione e al trattamento di malattie cardiovascolari e respiratorie, diabete, disturbi del sistema nervoso, ecc;
- prodotti OTC e integratori alimentari (12,7%);
- altro (0,5%).
Le vendite nette sono distribuite geograficamente come segue: Germania (5,1%), Svizzera (1,2%), Europa-Medio Oriente-Africa (23,2%), Stati Uniti (30,6%), Nord America (3,5%), Cina (7,6%), Asia-Pacifico (10%), Brasile (10,4%) e America Latina (8,4%).
Numero di dipendenti: 96 931
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Crop Science
48,8
%
| 25 169 | 49,6 % | 23 270 | 48,8 % | -7,54% |
Pharmaceuticals
38,0
%
| 19 252 | 37,9 % | 18 081 | 38,0 % | -6,08% |
Consumer Health
12,7
%
| 6 080 | 12,0 % | 6 027 | 12,7 % | -0,87% |
All Other
0,5
%
| 217 | 0,4 % | 238 | 0,5 % | +9,68% |
Enabling Functions and Consolidation
0,0
%
| 21 | 0,0 % | 21 | 0,0 % | 0,00% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
30,6
%
| 15 685 | 30,9 % | 14 587 | 30,6 % | -7,00% |
Europe/Middle East/Africa
23,2
%
| 11 352 | 22,4 % | 11 071 | 23,2 % | -2,48% |
Brazil
10,4
%
| 5 322 | 10,5 % | 4 967 | 10,4 % | -6,67% |
Asia/Pacific
10,0
%
| 5 192 | 10,2 % | 4 745 | 10,0 % | -8,61% |
Latin America
8,3
%
| 3 966 | 7,8 % | 3 961 | 8,3 % | -0,13% |
China
7,6
%
| 4 259 | 8,4 % | 3 624 | 7,6 % | -14,91% |
Germany
5,1
%
| 2 477 | 4,9 % | 2 448 | 5,1 % | -1,17% |
North America
3,5
%
| 1 886 | 3,7 % | 1 667 | 3,5 % | -11,61% |
Switzerland
1,2
%
| 600 | 1,2 % | 567 | 1,2 % | -5,50% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 01/04/23 |
Director of Finance/CFO | 54 | 26/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/04/20 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/21 |
- | - | ||
Heike Prinz
PRN | Corporate Officer/Principal | - | 01/09/23 |
Itziar Canamasas
PRN | Corporate Officer/Principal | 50 | - |
Ruzha Draganova
PRN | Corporate Officer/Principal | - | 01/01/15 |
Rodrigo Santos
PRN | Corporate Officer/Principal | 51 | - |
Miriam Holstein
PRN | Corporate Officer/Principal | - | 01/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 01/04/17 |
Director/Board Member | 68 | 01/04/17 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 01/04/21 |
Paul Achleitner
BRD | Director/Board Member | 67 | 01/04/02 |
Ertharin Cousin
BRD | Director/Board Member | 66 | 01/10/19 |
Director/Board Member | 66 | 28/04/20 | |
Heike Hausfeld
BRD | Director/Board Member | 58 | 01/01/94 |
André van Broich
BRD | Director/Board Member | 53 | 01/04/12 |
Frank Löllgen
BRD | Director/Board Member | 62 | 01/11/15 |
Director/Board Member | 64 | 01/04/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 982 424 082 | 982 167 123 ( 99,97 %) | 0 | 99,97 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
BAYER CROPSCIENCE LIMITED 71.43% | 32 102 999 | 71.43% | 2 018 136 412 $ |
CENTURY THERAPEUTICS, INC. 19.56% | 12 675 838 | 19.56% | 52 985 003 $ |
METAGENOMI, INC. 10.79% | 4 050 997 | 10.79% | 42 738 018 $ |
BOUNDLESS BIO, INC. 10.10% | 1 615 201 | 10.10% | 23 016 614 $ |
SENTI BIOSCIENCES, INC. 12.85% | 5 878 488 | 12.85% | 2 216 190 $ |
1 490 625 | 0.38% | 385 028 $ | |
AZITRA, INC. 4.55% | 1 307 401 | 4.55% | 269 325 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. |
Pharmaceuticals: Major
|
Schering Berlin, Inc.
Schering Berlin, Inc. Medical SpecialtiesHealth Technology Part of Bayer AG, Schering Berlin, Inc. is a private company that manufactures pharmaceuticals and diagnostic substances. The company is based in Whippany, NJ. |
Medical Specialties
|
Wholesale Distributors
| |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. |
Pharmaceuticals: Major
|
Seminis Vegetable Seeds, Inc.
Seminis Vegetable Seeds, Inc. Agricultural Commodities/MillingProcess Industries Seminis Vegetable Seeds, Inc. engages in plant breeding research and development services. It develops types of vegetables, which are marketed to commercial vegetable growers, dealers, distributors, and wholesalers. The firm’s products include Fresh Market, Home Garden, Processor, Performance Series Sweet Corn, SummerSlice Watermelons and Pepper X10R and Technology. The company was founded in 1865 and is headquartered in St. Louis, MO. |
Agricultural Commodities/Milling
|
Bayer CropScience Ltd. (United Kingdom)
Bayer CropScience Ltd. (United Kingdom) Chemicals: AgriculturalProcess Industries Bayer CropScience Ltd. manufactures and markets crop protection products. It offers fungicides, herbicides, insecticides, rodenticides and seeds. The firm also engages in the breeding, development, production, and marketing of hybrid seeds. The company is headquartered in Cambridge, the United Kingdom. |
Chemicals: Agricultural
|
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. |
Biotechnology
|
Intendis GmbH
Intendis GmbH Pharmaceuticals: MajorHealth Technology Intendis GmbH specializes in dermatological drugs. Its products are to treat acne, rosacea, eczema, psoriasis, and fungal infections. The company operates in Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, and the USA. It was founded in 2005 and is headquartered in Berlin, Germany. |
Pharmaceuticals: Major
|
Chemicals: Agricultural
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-18,53% | 28,74 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione BAYN
- Società Bayer AG